NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day). by Xueqin lu (22250795)

Subjects:

MXene/Bi₂O₃ Nanocomposites as Supercapacitors for Portable Electronic Devices by Nanasaheb M. Shinde (8560572)

Subjects:

Growth of <i>L</i>. <i>intracellularis</i> strains Dkp23 and Vaccine in PK-15 cell lines. by Huan W. Yang (19746645)

Subjects:

Association of <i>Shigella</i> infections with EE biomarker concentration over time. by Haley A. Liakakos (21445884)

Subjects:

PRV UL4 augments ASC oligomerization and speck formation. by Xiaohua Zhang (350570)

Subjects:

Normalized significant family changes in abundance. by Karley K. Mahalak (3212670)

“…<p>A) <i>Erysipelotrichaceae</i> significantly increased with CCE treatment; B) <i>Bacteroidales_unclassified</i> significantly decreased with CCE treatment; C) <i>Desulfovibrionaceae</i> significantly decreased with CCE treatment; D) <i>Rikenellaceae</i> significantly decreased with CCE treatment; E) <i>Coriobacteriaceae</i> significantly decreased with CCE treatment; F) <i>Erysipelotrichaceae</i> significantly increased with TRE treatment.…”

Good knowledge, good perception and acceptance of COVID-19 vaccine. by Adaobi Uchenna Mosanya (20384248)

Subjects:

Knowledge and acceptance of COVID-19 vaccine. by Adaobi Uchenna Mosanya (20384248)

Subjects:

Association between Sociodemographic and level of knowledge, perception, and acceptance of the respondents. by Adaobi Uchenna Mosanya (20384248)

Subjects:

Logistics regression COVID-19 vaccine predictors. by Adaobi Uchenna Mosanya (20384248)

Subjects:

Perception towards COVID-19 vaccine. by Adaobi Uchenna Mosanya (20384248)

Subjects:

The level of knowledge of the COVID-19 vaccine. by Adaobi Uchenna Mosanya (20384248)

Subjects:

Association between sociodemographic and level of knowledge, perception and acceptance of the respondents. by Adaobi Uchenna Mosanya (20384248)

Subjects:

Changes in the monthly contamination rate (per set) in blood culture (BC). by Miki Doi (15347878)

Subjects:

Patient background and blood culture-related factors before and after revision of the blood culture collection protocol. by Miki Doi (15347878)

Subjects:

Comparison of the blood culture contamination rate (per set) in each organism between the control and bundle periods. by Miki Doi (15347878)

Subjects:

Reasons for the determination of blood culture contamination for each organism. by Miki Doi (15347878)

Subjects:

Protocol for blood culture during the control period. by Miki Doi (15347878)

Subjects:

Semiannual analysis of monthly use of sterile blood transfer devices. by Miki Doi (15347878)

Subjects:

Semiannual analysis of monthly use of skin disinfection swab sets in the hospital. by Miki Doi (15347878)

Subjects: